Clinical Progress of PD-1/L1 Inhibitors in Breast Cancer Immunotherapy

Breast cancer is a major killer of women’s health worldwide. While breast cancer is thought to have lower immunogenicity compared with other solid tumors, combination therapy is able to improve the immunogenicity of the tumor and sensitize breast cancer cells to immunotherapy. Immunotherapy represen...

Descripción completa

Detalles Bibliográficos
Autores principales: Chen, Fei, Chen, Naifei, Gao, Yangyang, Jia, Lin, Lyu, Zheng, Cui, Jiuwei
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770281/
https://www.ncbi.nlm.nih.gov/pubmed/35070955
http://dx.doi.org/10.3389/fonc.2021.724424

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8770281/
https://www.ncbi.nlm.nih.gov/pubmed/35070955
http://dx.doi.org/10.3389/fonc.2021.724424

Ejemplares similares